Abbonarsi

ILEAL URETER - 11/09/11

Doi : 10.1016/S0094-0143(05)70422-5 
Rogério M. Mattos, MD *, John J. Smith, MD *

Riassunto

The search for an optimal method for reconstruction or replacement of the diseased ureter is a classic example of the way urologists seek solutions to complex genitourinary problems. Numerous types of grafts have failed, including those using blood vessels, fallopian tubes, peritoneal tubes, and metal and plastic. Ureteral replacement with ileal bowel segments has become part of the urologic surgeon's armamentarium more than 35 years after Goodwin et al10 first popularized the procedure.

Fenger7 is credited with the first written proposal for reconstructing the ureter with small bowel. In 1900, the operation was successfully performed on three dogs by d'Urso and de Fabii.6 In 1906, Shoemaker18 carried out the first repair in a human by replacing the ureter of an 18-year-old woman who was presumed to have genitourinary tuberculosis. Melnikoff15 published a classic treatise in 1912 on the history of the procedure but, by 1950, only three case reports were found in the literature. In 1959, the summary by Goodwin et al10 popularized the procedure.

In general, the indications for intestinal replacement of the ureter remain the same today:

Recurrent calculi
Extensive ureteral injury
Retroperitoneal fibrosis
Ureteral stricture
Fistula
Tuberculosis
Ureteral carcinoma in solitary kidney
Undiversion
Congenital obstruction
Schistosomiasis

This is because ileal ureter reconstruction should usually be considered when all other more conservative procedures, such as ureteroneocystostomy, ureterocalicostomy, Boari flap, transureteroureterostomy, and in some cases autotransplantation, are not applicable.

Contraindications to ileal ureter replacement include an inadequate length of usable bowel or inflammatory bowel disease:

Ileal disease (inflammatory bowel disease)
Incontinence
Bladder neck obstruction
Neurogenic bladder
Metastatic disease
Renal failure
Hepatic dysfunction

Patients with hepatic dysfunction are at risk for the development of hepatic encephalopathy secondary to absorption of nitrogenous waste into the enteric circulation. This risk is particularly noteworthy in a patient with portacaval shunt.14 Furthermore, to avoid high-pressure reflux and subsequent renal deterioration, any difficulty with emptying the bladder should be evaluated and ruled out before operation.

Pre-existing azotemia has been a relative contraindication, particularly when the serum level of creatinine is greater than 2 mg/dL. Infrequently, however, we are faced with a patient with a level of creatinine greater than 2 mg/dL who wishes to risk metabolic complications to avoid a less palatable alternative. We recommend using a much smaller area of bowel as a segment or interposition graft. The safe use of small segments with caution to replace damaged ureters has been reported by Casale et al5 and Lytton and Schiff13 in humans and Waters et al24 in dogs.

Experience at the Lahey Hitchcock Medical Center now totals 61 ureteral replacements. In this group were 17 solitary kidneys and 11 segmental replacements, 3 of which are true interposition grafts.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Address reprint requests to John J. Smith III, MD Department of Urology Lahey Hitchcock Medical Center 41 Mall Road Burlington, MA 01805


© 1997  W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.© 1997  © 1997  © 1997  © 1997  © 1997  © 1997  © 1997  © 1997  © 1997  © 1997  © 1997 
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 24 - N° 4

P. 813-825 - novembre 1997 Ritorno al numero
Articolo precedente Articolo precedente
  • THE MITROFANOFF PRINCIPLE IN CONTINENT URINARY RECONSTRUCTION
  • Martin Kaefer, Alan B. Retik
| Articolo seguente Articolo seguente
  • THE ILEAL NEOBLADDER TO THE FEMALE URETHRA
  • Richard E. Hautmann

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.